Van Hoef Consulting

Van Hoef Consulting, founded in 2010 and based in Grenchen, Switzerland, is a boutique consultancy serving the biopharmaceutical sector. Led by founder Dr. Marlies Van Hoef, the firm leverages deep clinical and regulatory expertise to guide clients through translational research, clinical trials (Phase I-IV), and post-launch medical affairs, primarily in oncology and hematology. Operating as a service provider, its business model is based on project-based consulting, making it a flexible partner for biotech and pharma companies seeking specialized external guidance. The company is a private, revenue-generating entity that fills a niche for high-level, therapeutic-area-specific strategic support.

Integrated expertise platform combining deep clinical knowledge (board-certified MD in oncology/hematology), drug development experience (pharma/biotech/CRO), regulatory insight (former Swissmedic), and real-world evidence capabilities (registry experience).

Competes with large global consulting/CRO firms (e.g., IQVIA, Parexel) and numerous boutique life science consultancies. Differentiation is based on deep, specific therapeutic area expertise, firsthand regulatory experience, and the personalized service of a founder-led firm.